What's new

Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 23, Status: Authorised

Apr 28, 2025 - 15:18
 0
Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

Regeneron scores EU nod for bispecific antibody Lynozyfic, setting up clash with...

Next Article

Big Oil braced for worst year since pandemic as bumper profits recede

Related Posts

Human medicines European public assessment report (EPAR): Brilique, ticagrelor, Date of authorisation: 03/12/2010, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Positive

Orphan designation: Zanidatamab Treatment of biliary tr...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0